What inherited genetic mechanisms underlie familial non-small cell lung cancer?
DOI:
https://doi.org/10.58445/rars.1205Keywords:
lung cancer, non small cell lung cancer, biomedical sciences, geneticsAbstract
Lung cancer is the leading cause of cancer deaths worldwide for both men and women. Oftentimes, this can occur through the inheritance of gene mutations. When these are frequently found in families, these cases are called familial cancer syndromes. One example of a cancer with possible genetic influence is non-small cell lung cancer (NSCLC). Our goal is to identify what inherited genetic mechanisms underlie familial non-small cell lung cancer. This paper will begin by looking at the epidemiology of NSCLC and then identifying the specific genes that are associated with it in families. In particular, we will look into mutations of the genes EGFR, ALK, HER2, KRAS, and p53 because of their occurrence in NSCLC cases as well as research done using genome wide association studies. We examined these genes in order to understand the specific genetic mechanisms that cause NSCLC. We did this by reviewing and interpreting the data from primary research articles. In the end, we were able to identify how EGFR, ALK, HER2, KRAS are tumor promoters, while p53 is a tumor suppressor. We also examined specific inhibitors that are available to cancer patients who are afflicted with these mutations. Using this data, we hope to inform afflicted patients and their families about their mutations, as well as potential treatment options.
References
American cancer society. “Lung Cancer Statistics | How Common Is Lung Cancer?” Www.cancer.org, 12 Jan. 2023, www.cancer.org/cancer/types/lung-cancer/about/key-statistics.html .
“Cancer Today.” Gco.iarc.who.int, gco.iarc.fr/today/en/fact-sheets-cancers.
Chaitanya Thandra, Krishna, et al. “Epidemiology of Lung Cancer.” Współczesna Onkologia, vol. 25, no. 1, 23 Feb. 2021, pp. 45–52, www.ncbi.nlm.nih.gov/pmc/articles/PMC8063897/, https://doi.org/10.5114/wo.2021.103829.
Bray, Freddie, et al. “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: A Cancer Journal for Clinicians, vol. 68, no. 6, 12 Sept. 2018, pp. 394–424, acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21492, https://doi.org/10.3322/caac.21492.
“Https://Www.cancer.gov/Publications/Dictionaries/Cancer-Terms/Def/Non-Small-Cell-Lung-Cancer.” Www.cancer.gov, 2 Feb. 2011, www.cancer.gov/publications/dictionaries/cancer-terms/def/non-small-cell-lung-cancer.
“Lung Cancer Types.” Www.hopkinsmedicine.org, www.hopkinsmedicine.org/health/conditions-and-diseases/lung-cancer/lung-cancer-types#:~:text=Adenocarcinoma%20is%20the%20most%20common.
Stadler, Zsofia K., et al. “Genome-Wide Association Studies of Cancer.” Journal of Clinical Oncology, vol. 28, no. 27, 20 Sept. 2010, pp. 4255–4267, www.ncbi.nlm.nih.gov/pmc/articles/PMC2953976/, https://doi.org/10.1200/JCO.2009.25.7816.
Medline Plus. “TP53 Gene: MedlinePlus Genetics.” Medlineplus.gov, 18 Aug. 2020, medlineplus.gov/genetics/gene/tp53/.
CDC. “What Are the Risk Factors for Lung Cancer? | CDC.” Www.cdc.gov, 15 July 2020, www.cdc.gov/cancer/lung/basic_info/risk_factors.htm#:~:text=In%20the%20United%20States%2C%20cigarette.
“How Does Smoking Cause Cancer?” Cancer Research UK, 28 Dec. 2018, www.cancerresearchuk.org/about-cancer/causes-of-cancer/smoking-and-cancer/how-does-smoking-cause-cancer#:~:text=Cigarette%20smoke%20contains%20over%205000.
“Cigarette Smoke Produces 10 Times More Air Pollution than Diesel Car Exhaust.” Medical News Today, www.medicalnewstoday.com/releases/12481#:~:text=Those%20recorded%20in%20the%20first.
Molina, Julian R, et al. “Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship.” Mayo Clinic Proceedings, vol. 83, no. 5, 2008, pp. 584–94, https://doi.org/10.4065/83.5.584.
“Red Meat, Processed Meat and Cancer.” Cancer Council NSW, www.cancercouncil.com.au/1in3cancers/lifestyle-choices-and-cancer/red-meat-processed-meat-and-cancer/#:~:text=In%20addition%2C%20the%20nitrite%20and.
Thorgeirsson, Thorgeir E., et al. “A Variant Associated with Nicotine Dependence, Lung Cancer and Peripheral Arterial Disease.” Nature, vol. 452, no. 7187, Apr. 2008, pp. 638–642, https://doi.org/10.1038/nature06846.
Chaitanya Thandra, Krishna, et al. “Epidemiology of Lung Cancer.” Współczesna Onkologia, vol. 25, no. 1, 23 Feb. 2021, pp. 45–52, www.ncbi.nlm.nih.gov/pmc/articles/PMC8063897/, https://doi.org/10.5114/wo.2021.103829.
Stadler, Zsofia K., et al. “Genome-Wide Association Studies of Cancer.” Journal of Clinical Oncology, vol. 28, no. 27, 20 Sept. 2010, pp. 4255–4267, www.ncbi.nlm.nih.gov/pmc/articles/PMC2953976/, https://doi.org/10.1200/JCO.2009.25.7816.
Kurn, Heidi, and Daniel T. Daly. “Histology, Epithelial Cell.” PubMed, StatPearls Publishing, 2023, www.ncbi.nlm.nih.gov/books/NBK559063/#:~:text=Epithelial%20cells%20are%20among%20the.
“Types of Cancer.” Cancer Research UK, 28 Oct. 2014, www.cancerresearchuk.org/about-cancer/what-is-cancer/how-cancer-starts/types-of-cancer#:~:text=carcinoma%20%E2%80%93%20this%20cancer%20begins%20in.
Uribe, Mary Luz, et al. “EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance.” Cancers, vol. 13, no. 11, 1 June 2021, p. 2748, www.ncbi.nlm.nih.gov/pmc/articles/PMC8197917/
Zhao, Ruiying, et al. Identification and Therapeutic Evaluation of ALK Rearrangements in Non‐Small‐Cell Lung Cancer. 18 July 2022, https://doi.org/10.1002/cjp2.289.
“ALK and Lung Cancer.” Www.lung.org, www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing/alk-lung-cancer.
What is ALK — ALK POSITIVE. “ALK POSITIVE.” ALK POSITIVE, 2014, www.alkpositive.org/what-is-alk.
Association, American Lung. “HER2 and Lung Cancer.” Www.lung.org, www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing/her2.
Robichaux, Jacqulyne P., et al. “Mechanisms and Clinical Activity of an EGFR and HER2 Exon 20–Selective Kinase Inhibitor in Non–Small Cell Lung Cancer.” Nature Medicine, vol. 24, no. 5, 23 Apr. 2018, pp. 638–646, www.nature.com/articles/s41591-018-0007-9.
“KRAS Gene: MedlinePlus Genetics.” Medlineplus.gov, medlineplus.gov/genetics/gene/kras/#conditions.
Ihle, Nathan T., et al. “Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome.” JNCI: Journal of the National Cancer Institute, vol. 104, no. 3, 8 Feb. 2012, pp. 228–239, academic.oup.com/jnci/article/104/3/228/973198?login=true.
National Cancer Institute. “Https://Www.cancer.gov/Publications/Dictionaries/Cancer-Terms/Def/P53-Gene.” Www.cancer.gov, 2 Feb. 2011, www.cancer.gov/publications/dictionaries/cancer-terms/def/p53-gene.
Medline Plus. “TP53 Gene: MedlinePlus Genetics.” Medlineplus.gov, 18 Aug. 2020, medlineplus.gov/genetics/gene/tp53/.
Foord, Orit Shohat, et al. “A DNA Binding Domain Is Contained in the C-Terminus ofWild TypeP53 Protein.” Nucleic Acids Research, vol. 19, no. 19, 1991, pp. 5191–5198, dpl6hyzg28thp.cloudfront.net/media/19-19-5191.pdf.
Downloads
Posted
Categories
License
Copyright (c) 2024 Ivana Ma
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.